Dextran–Hesperetin Conjugate as a Novel Biocompatible Medicine for Antimicrobial and Anticancer Applications

Hesperidin (HD), a bioflavanone glycoside, was isolated from orange peel and converted to hesperetin (HT) using a simple and efficient green procedure. Then dextran-hesperetin conjugate (Dex-HT) was prepared by free radical grafting reaction and the functionalization degree of it was assessed by the Folin–Ciocalteu method. The antioxidant activity of HD, HT and Dex-HT was tested by DPPH⋅ radical method. Presence of dextran as a backbone in the Dex-HT structure, improved antioxidant activities of the hesperetin. In addition, antimicrobial effect of these compounds was evaluated against some food pathogens ( Listeria monocytogenes and Salmonella typhimurium ). According to the results, L. monocytogenes was more sensitive to these compounds than S. typhimurium . Also, Dex-HT was more bacteriostatic than HD and HT. In addition, cytotoxic effect of Dex-HT against MCF-7(human breast adenocarcinoma), AGS (gastric adenocarcinoma) and normal fibroblast cells was determined in 48 and 72 h using MTT assay. The outcomes indicated that Dex-HT induced a significant dose-dependent cytotoxic effect on both AGS and MCF-7 cells. Moreover, Dex-HT showed a greater cytotoxic effect on MCF-7 cells than on AGS and normal cells. In this study, dextran, a biodegradeble carbohydrate polymer, was employed as a versatile scaffold to develop highly efficient antioxidant, antibacterial and anticancer hybrid material.